Differential expression of microRNA and predicted targets in pulmonary sarcoidosis

Biochemical and Biophysical Research Communications

Volumn 417, Issue 2, 2012, Pages 886-891

  Crouser, Elliott D ^a   Julian, Mark W ^a   Crawford, Melissa ^a   Shao, Guohong ^a   Yu, Lianbo ^b   Planck, Stephen R ^c   Rosenbaum, James T ^c   Patrick Nana Sinkam, S ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Gene; Granuloma; Lung; MicroRNA; Peripheral blood mononuclear cells; TGF

Indexed keywords

INTEGRASE; MICRORNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG PARENCHYMA; LYMPH NODE; MICROARRAY ANALYSIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SARCOIDOSIS; SIGNAL TRANSDUCTION;

GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTEGRASES; LUNG; LYMPH NODES; MICRORNAS; MOLECULAR TARGETED THERAPY; SARCOIDOSIS, PULMONARY; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 84855826395     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.068     Document Type: Article

References (45)

1. Wijnen P.A., Voorter C.E., Nelemans P.J., Vershakelen J.A., Bekers O., Drent M. Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression?. Hum. Immunol. 2011, 72:342.
2. Grunewald J. Review: role of genetics in susceptibility and outcome of sarcoidosis. Semin. Respir. Crit. Care Med. 2010, 31:380.
3. Jonth A.C., Silveira L., Fingerlin T.E., et al. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J. Immunol. 2007, 179:4255.
4. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704.
5. Liu G., Friggeri A., Yang Y., et al. MiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 2010, 207:1589.
6. Ezzie M.E., Crawford M., Cho J., et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 2011, (PMID: 21940491).
7. Crouser E.D., Culver D.A., Knox K.S., et al. Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 2009, 179:929.
8. Rosenbaum J.T., Pasadhika S., Crouser E.C., et al. Hypothesis: sarcoidosis is a STAT1-mediated disease. Clin. Immunol. 2009, 132:174.
9. Koth L.L., Soldberg O.D., Peng J.C., Bhakta N.R., Nguyen C.P., Woodruff P.G. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am. J. Respir. Crit. Care Med. 2011, (PMID: 21852540).
10. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215.
11. Labbé E., Lock L., Letamendia A., et al. Transcriptional cooperation between the transforming growth factor-beta and WNT pathways in mammary and intestinal tumorigenesis. Cancer Res. 2007, 67:75.
12. American Thoracic Society Statement on Sarcoidosis. Am. J. Respir. Crit. Care Med. 160 (1999) 736.
13. Auer H., Liyanarachchi S., Newsom D., Klisovic M.I., Marcucci G., Kornacker K. Chipping away at the chip bias: RNA degradation in microarray analysis. Nat. Genet. 2003, 35:292.
14. Liu C.G., Calin G.A., Volinia S., Croce C.M. MicroRNA expression profiling using microarrays. Nat. Protoc. 2008, 3:563.
15. Irizarry R., Hobbs B., Collin F., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249.
16. Smyth G.K. Linear models and empirical Bayes methods for assessing differentially expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3:3.
17. Sartor A.M., Tomlinson R.C., Wesselkamper C.S., Sivaganesan S., Leikauf D.G., Medvedovic M. Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinformatics 2006, 7:358.
18. Gordon A., Glazko G., Qiu X., Yakovlev A. Control of the mean number of false discoveries, Bonferroni and stability of multiple testing. Ann. Appl. Stat. 2007, 1:179.
19. Johnson R.A., Wichern D.W. Applied Multivariate Statistical Analysis 2000, Prentice Hall, New Jersey. fourth ed.
20. Papadopoulos G.L., Alexious P., Maraqkakis M., Reczko M., Hatzigeorgiou A.G. DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 2009, 25:1991.
21. Hunninghake G.W., Gadek J.E., Young R.C., Kawanami O., Ferrans V.J., Crystal R.G. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N. Engl. J. Med. 1980, 302:594.
22. Pera M.F., Tam P.P. Extrinsic regulation of pluripotent stem cells. Nature 2010, 465:713.
23. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336.
24. Xiao C., Rajewsky R. MicroRNA control in the immune system: basic principles. Cell 2009, 136:26.
25. Hassan M.Q., Gordon J.A., Beloti M.M., et al. A network connecting Runx2, SATB2 and the miR-23a∼27a∼24-2 cluster regulates the osteoblastic differentiation program. Proc. Natl. Acad. Sci. USA 2010, 107:19879.
26. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199.
27. Flavell R.A., Sanjabi S., Wrzesinski S.H., Licona-Limon P. The polarization of immune cells in the tumour environment by TGFbeta. Nat. Rev. Immunol. 2010, 10:554.
28. Toossi Z., Gogate P., Shiratsuchi H., Young T., Ellner J.J. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J. Immunol. 1995, 154:465.
29. Limper A.H., Colby T.V., Sanders M.S., Asakura S., Roche P.C., DeRemee R.A. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 1994, 149:197.
30. Zissel G., Homolka J., Schlaak J., Schlaak M., Müller-Quernheim J. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 1996, 154:713.
31. Pabst S., Fränken T., Schönau J., et al. Transforming growth factor-{beta} gene polymorphisms in different phenotypes of sarcoidosis. Eur. Respir. J. 2011, 38:169.
32. Kruit A., Grutters J.C., Ruven H.J., et al. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 2006, 129:1584.
33. Licona-Limón P., Soldevila G. The role of TGF-β superfamily during T cell development: new insights. Immunol. Lett. 2007, 109:1.
34. Facco M., Cabrelle A., Teramo A., et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 2011, 66:144.
35. Wang K., Zhang S., Marzolf B., et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. USA 2009, 106:4402.
36. Staal F.J., Luis T.C., Tiemessen M.M. WNT signaling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 2008, 8:581.
37. Blumenthal A., Ehlers S., Lauber J., et al. The wingless homolog WNT5A and its receptor frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 2006, 108:965.
38. Neumann J., Schaale K., Farhat K., et al. Frizzled1 is a marker of inflammatory macrophages, and its ligand WNT3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB J. 2010, 24:4599.
39. Kleinhenz M.E., Ellner J.J., Spagnuolo P.J., Daniel T.M. Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility. J. Clin. Invest. 1981, 68:153.
40. Miyara M., Amoura Z., Parizot C., et al. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 2006, 203:359.
41. Hudspith B.N., Flint K.C., Geraint-James D., Brostoff J., Johnson N.M. Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response. Thorax 1987, 42:250.
42. Levanen B., Wheelock A.M., Eklund A., Grunewald J., Nord M. Increased pulmonary WNT (wingless/integrated)-signaling in patients with sarcoidosis. Respir. Med. 2011, 105:282.
43. Pandit K.V., Milosevic J., Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl. Res. 2011, 157:191.
44. Pandit K.V., Corcoran D., Yousef H., et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 2010, 182:220.
45. Benes V., Castoldi M. Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods 2010, 50:244.